glp1 journey and tirzepatide dosage Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide dose chart: complete dosing

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, GLP-1 weight management support, longevity protocols, and related precision wellness services

Read user reviews mentioning nausea and vomiting Diarrhea Diarrhea is a common side effect of Wegovy

Furthermore, patients were recommended to avoid alcohol, coffee and tea during the study

If fatigue remains problematic despite optimisation strategies, discuss with your healthcare provider whether Wegovy remains the most appropriate treatment option

Bibcode:2004PNAS..10110919F

However, there are eligibility requirements